Life science company Bayer steps up focus on research and development
The Bayer Group plans in the future to sharpen its focus on innovation in its life science businesses, HealthCare and CropScience. “Overall, we expect the R&D-to-sales ratio to increase in the coming years,” said Management Board Chairman Dr. Marijn Dekkers on Tuesday, addressing some 140 j ... more
Bayer completes acquisition of Dihon Pharmaceutical Group Co., Ltd.
Bayer has completed the acquisition of 100 percent of the shares of Dihon Pharmaceutical Group Co., Ltd., Kunming, Yunnan, China, a privately held pharmaceutical company specializing primarily in over-the-counter (OTC) dermatology products and herbal traditional Chinese medicine (TCM) produ ... more
Bayer operationally strong – strategic focus on Life Science businesses
The Bayer Group continued its successful business development. “The strong upward trend in the Life Science businesses – HealthCare and CropScience – persisted in the third quarter. We saw robust sales growth for our recently launched pharmaceutical products and in our CropScience business ... more